XML 12 R4.htm IDEA: XBRL DOCUMENT v3.25.2
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Pre-funded warrant
Common Stock
Common Stock
Pre-funded warrant
Additional Paid-In Capital
Additional Paid-In Capital
Pre-funded warrant
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning Balance at Dec. 31, 2023 $ 273,285   $ 5   $ 708,706   $ 8 $ (435,434)
Beginning Balance, Shares at Dec. 31, 2023     49,181,295          
Issuance of common stock upon exercise of stock options 578 $ 225,073     578 $ 225,071    
Issuance of common stock upon exercise of stock options, Shares     128,671 21,010,000        
Issuance of common stock, net of issuance costs       $ 2        
Issuance of common stock upon vesting of restricted stock units, Shares     133,595          
Share-based compensation expense 4,368       4,368      
Unrealized loss on investments (135)           (135)  
Net loss (29,518)             (29,518)
Ending Balance at Mar. 31, 2024 473,651   $ 7   938,723   (127) (464,952)
Ending Balance, Shares at Mar. 31, 2024     70,453,561          
Beginning Balance at Dec. 31, 2023 273,285   $ 5   708,706   8 (435,434)
Beginning Balance, Shares at Dec. 31, 2023     49,181,295          
Net loss (54,511)              
Ending Balance at Jun. 30, 2024 453,184   $ 7   943,385   (263) (489,945)
Ending Balance, Shares at Jun. 30, 2024     70,558,546          
Beginning Balance at Mar. 31, 2024 473,651   $ 7   938,723   (127) (464,952)
Beginning Balance, Shares at Mar. 31, 2024     70,453,561          
Issuance of common stock upon exercise of stock options 90       90      
Issuance of common stock upon exercise of stock options, Shares     14,382          
Issuance of common stock upon vesting of restricted stock units, Shares     22,072          
Common stock issued under employee stock purchase plan 158       158      
Common stock issued under employee stock purchase plan, Shares     68,531          
Share-based compensation expense 4,414       4,414      
Unrealized loss on investments (136)           (136)  
Net loss (24,993)             (24,993)
Ending Balance at Jun. 30, 2024 453,184   $ 7   943,385   (263) (489,945)
Ending Balance, Shares at Jun. 30, 2024     70,558,546          
Beginning Balance at Dec. 31, 2024 407,976   $ 7   951,519   674 (544,224)
Beginning Balance, Shares at Dec. 31, 2024     70,645,139          
Issuance of common stock upon vesting of restricted stock units, Shares     312,415          
Share-based compensation expense 2,834       2,834      
Unrealized loss on investments (22)           (22)  
Net loss (31,983)             (31,983)
Ending Balance at Mar. 31, 2025 378,805   $ 7   954,353   652 (576,207)
Ending Balance, Shares at Mar. 31, 2025     70,957,554          
Beginning Balance at Dec. 31, 2024 407,976   $ 7   951,519   674 (544,224)
Beginning Balance, Shares at Dec. 31, 2024     70,645,139          
Net loss (54,960)              
Ending Balance at Jun. 30, 2025 357,668   $ 7   956,483   362 (599,184)
Ending Balance, Shares at Jun. 30, 2025     71,024,512          
Beginning Balance at Mar. 31, 2025 378,805   $ 7   954,353   652 (576,207)
Beginning Balance, Shares at Mar. 31, 2025     70,957,554          
Issuance of common stock upon vesting of restricted stock units, Shares     14,827          
Common stock issued under employee stock purchase plan 77       77      
Common stock issued under employee stock purchase plan, Shares     52,131          
Share-based compensation expense 2,053       2,053      
Unrealized loss on investments (290)           (290)  
Net loss (22,977)             (22,977)
Ending Balance at Jun. 30, 2025 $ 357,668   $ 7   $ 956,483   $ 362 $ (599,184)
Ending Balance, Shares at Jun. 30, 2025     71,024,512